DP
CANO

Dearborn Partners’s Cano Health, Inc. CANO Stock Holding History

Dearborn Partners’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-135
Closed -$3.42K – 262
2023
Q3 		$3.42K Hold
135
– – ﹤0.01% 237
2023
Q2 		$18.8K Hold
135
– – ﹤0.01% 236
2023
Q1 		$12.3K Buy
135
+15
+13% +$2.04K ﹤0.01% 242
2022
Q4 		$16.4K Buy
+120
New +$40.6K ﹤0.01% 245

Other funds holding CANO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dearborn Partners's CANO Position: Q4 2023 in Review

Dearborn Partners sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 135 shares — an estimated $3.42K sold.

Dearborn Partners first reported a position in CANO in Q4 2022 and held it in 4 quarters. The position peaked at $18.8K in Q2 2023. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Dearborn Partners reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Dearborn Partners sold 135 Cano Health, Inc. shares in Q4 2023, an estimated $3.42K.
  • Dearborn Partners first reported a position in Cano Health, Inc. in Q4 2022 and held it in 4 quarters.
  • Dearborn Partners's Cano Health, Inc. position peaked at $18.8K in Q2 2023.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Dearborn Partners's 13F filing for Q4 2023, filed 26 Jan 2024.